<DOC>
	<DOCNO>NCT02865837</DOCNO>
	<brief_summary>The purpose study compare , patient , dosimetry organ risk ( bladder , rectum , sigmoid , small bowel ) two bladder distension procedure ( emptied urinary catheter fill 120cc ) PDR 3D image-guided brachytherapy cervical cancer .</brief_summary>
	<brief_title>Effect Bladder Distension Dosimetry Brachytherapy Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Urinary Retention</mesh_term>
	<criteria>Age &gt; = 18 year old cervical cancer histologically proven ( squamous cell carcinoma , adenocarcinoma neuroendocrine cell carcinoma ) Uterovaginal brachytherapy indication : : Stage 1B1 : brachytherapy surgery Stages IB2 IIIB : pelvic radiotherapy ( 45Gy/25 fractions/5 week ) without concomitant chemotherapy Ability provide inform write consent form Patient must affiliate social security system Age &lt; 18 year old History pelvic radiotherapy History pelvic surgery Recent joint prothesis ( &lt; 3 month ) Pregnant woman breastfeed Patients deprive liberty supervision</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Brachytherapy</keyword>
	<keyword>Organs Risk</keyword>
	<keyword>Bladder volume</keyword>
	<keyword>Cervical cancer</keyword>
</DOC>